Symbiotic appoints former Société Générale Asset Management APAC CEO Mahendran Nathan as Global Head of Onchain Solutions. September 02, 2026 08:15 ET | Source: Symbiotic GEORGE TOWN, Cayman Islands, Sept. 02, 2026 (GLOBE NEWSWIRE) - Symbiotic, the collateral markets platform backed by Paradigm, Pantera Capital, cyber - Fund, and Coinbase Ventures, today announced the appointment of Mahendran Nathan as Global Head of Onchain Solutions, effective August 2026, bringing more than 25 years of institutional asset management, capital formation and investment experience to Symbiotic's global expansion. Based in Singapore, Nathan joins as Symbiotic expands its focus on bringing institutional-scale capital into onchain markets. The industry has spent years building the technical infrastructure for assets and financial applications to operate onchain. The next phase depends on connecting that infrastructure to the institutions that manage the majority of global capital, and building the investment structures, governance, liquidity and reporting they require to participate. Nathan brings deep practitioner-level experience in institutional asset management, product development and capital formation. As CEO and Regional Head of Société Générale Asset Management for Asia Pacific, he scaled the firm's regional platform from $300 million to $15 billion in AUM across global markets in seven years, winning mandates from sovereign wealth, central banks, pension funds, insurers and building the firm's UHNW distribution. He later served as CEO for ASEAN, Hong Kong, Taiwan and India at Russell Investments. Since 2022, he has invested as an allocator across public and private markets, including global equities, private equity, private credit and real assets. "The next phase of digital asset adoption depends on institutional capital moving onchain," said Misha Putiatin, co-founder of Symbiotic. "Pension funds, insurers and sovereign wealth funds need structures they can underwrite, reporting they can reconcile and governance they can approve. Symbiotic is building the collateral infrastructure for institutional capital to support credit, insurance, RWA liquidity and other onchain financial obligations under code-enforced terms. Mahen has spent his career raising and structuring capital for these institutions, then allocating it himself. His experience brings us closer to making institutional-scale onchain markets real." At Symbiotic, Nathan will lead the design of investment solutions for asset owners and allocators, alongside capital formation and institutional coverage across the US, EMEA and APAC over time. His remit includes adapting structures, liquidity profiles, reporting and governance to the requirements of different investor types. "My work has always started with the investor's problem, not the product. Over twenty-five years, that has meant designing mandates, structured products and investment solutions around what different allocators actually need and more recently, sitting on the other side of the table making allocation decisions. Good investment thinking dies in the operational layer far more than it does in the portfolio. That is the layer Symbiotic is rebuilding. "A pension fund, an insurer, a private bank, a family office, a corporate treasury and an onchain-native investor are not one audience. They need different structures, liquidity profiles, reporting and governance around the same exposure. My job is to design the right solution for each of them - and to hold those solutions to the scrutiny as their traditional counterparts. That is how we open these markets to a much broader base of institutional capital." - Mahendran Nathan, Global Head of Onchain Solutions at Symbiotic. Nathan's appointment marks a new phase in Symbiotic's institutional expansion, bringing investment solution design and capital formation directly into the company as it scales collateral markets across credit, insurance, liquidity and tokenized assets. About Symbiotic Symbiotic is the collateral markets platform connecting capital to onchain applications. It enables institutional curators to build underwriting and capital-allocation strategies across credit, insurance, and RWAs. Backed by Paradigm, Pantera, Coinbase Ventures, and cyber - Fund, Symbiotic powers financial products for platforms including Cap Labs. Contact data. Release Summary Executive who scaled Société Générale Asset Management's Asia Pacific platform from $300M to $15B joins Symbiotic as institutional finance moves onchain Recommended reading.

Centrifuge adds Symbiotic liquidity network across $1.6B tokenized funds. 1 hour ago Centrifuge has added Symbiotic's liquidity network across three tokenized funds that represent about $1.6 billion in assets under management, giving eligible holders another route to exchange their positions for USDC. The integration covers Janus Henderson's JAAA, an AAA-rated collateralized loan obligation strategy, JTRSY, a short-duration US Treasury strategy and New York Life Investment Management's HYB, a US high-yield corporate bond strategy. Symbiotic's Liquid Lane uses an onchain request-for-quote (RFQ) marketplace where market makers can tap liquidity from vaults to fill redemption requests. Market makers can then redeem the acquired fund tokens through the issuer or sell them through another RFQ transaction. The arrangement allows investors to receive USDC immediately while the funds' normal redemption can take place separately. Centrifuge is an asset tokenization and vault platform where asset managers issue and manage tokenized funds. Janus Henderson, a global asset manager with about $500 billion in assets under management, has been a significant contributor to the platform's growth through its JAAA and JTRSY products. By December 2025, Centrifuge had attracted about $1.3 billion in new inflows, driven primarily by the two Janus Henderson funds, according to Token Terminal. JAAA alone had contributed about $1 billion in total value locked and was one of the largest tokenized funds in the market. Symbiotic joins existing liquidity routes. Liquid Lane is not the first liquidity route available for Centrifuge's tokenized funds, Felix Lutsch, Symbiotic's head of ecosystem, told Cointelegraph. "We're not claiming to be first, and other liquidity routes exist. That's healthy for the market," Lutsch said. Centrifuge announced a partnership with Wintermute in February 2025 to provide 24/7 instant redemptions for JTRSY. HYB launched in June with a separate liquidity arrangement for near-instant redemptions. Lutsch said the distinction with Liquid Lane is the capital structure behind the transactions rather than their speed. Its marketplace allows multiple market makers and curators to participate without market makers having to pre-fund and carry inventory for individual assets, he said. "The bigger constraint has been flow," Lutsch said, adding that low trading volumes in tokenized assets have historically given market makers little incentive to commit capital. He said aggregating redemption demand across issuers and asset classes could improve those economics as tokenized funds are increasingly used as collateral and financing assets in onchain markets. Magazine: 'Fabricated rumors' about BitMart founder, Binance bStocks dominate: Asia Express

Symbiotic launches Core V2, bringing shared collateral to insurance, credit, and tokenized assets. * 2 hrs ago GEORGE TOWN, Cayman Islands, July 01, 2026 (GLOBE NEWSWIRE) - Symbiotic, the collateral markets platform backed by Paradigm, Pantera Capital, CyberFund, and Coinbase Ventures, today launched Symbiotic Core V2, an infrastructure upgrade that lets applications across insurance, credit, and tokenized asset liquidity draw on shared collateral infrastructure, with each vault's risk and terms defined separately, while capital stays productive in lending markets when it is not actively needed. Symbiotic became known for shared security, the category much of the market calls restaking, but a growing number of applications began using it to back financial obligations rather than secure networks. Core V2 formalizes that shift. Jared Bernstein on California's Critical Primary Elections More than $7 trillion sits parked in US money market funds today, most of it earning a single rate and doing a single job. However, capital that backs more than one obligation at once is not new to finance. Arranging it takes legal teams, outside advisors, and months of structuring, so in practice it stays limited to the largest institutions, and everyone else's capital sits committed to a single purpose at a time. That is the ceiling on how efficiently collateral can work. Core V2 removes that ceiling. According to Symbiotic's capital efficiency analysis, capital deployed through Symbiotic vaults can be approximately 70 percent more efficient than equivalent standalone liquidity pools. Core V2 turns collateral into a shared base that applications across insurance, credit, and tokenized asset liquidity can draw from, each vault under its own risk terms and enforcement, so capital is reused across the system instead of locked into one single-purpose pool. Allocation limits, accepted collateral, recall conditions, and loss terms are set per vault and enforced by code. The capital backing an obligation earns continuously, generating returns across base lending yield, premiums, and redemption spreads. This runs on Capital Facilities, the framework that coordinates how vault capital is made available, used, and recalled. Capital committed to a vault does not have to sit idle while it waits for an obligation, because curators can route it into whitelisted, blue-chip lending protocols, Aave and Morpho, where it earns a base yield while remaining bound to its Symbiotic obligations. When an obligation is triggered, the capital is recalled from the adapter and enforcement proceeds without manual intervention. Providers can earn from base staking yield, premiums for backing obligations, and the lending return on capital. "Collateral markets are not a new financial idea. What is new is making them composable, enforceable, and capital-efficient onchain. Onchain finance cannot scale if every application has to rebuild its own capital pool. It needs collateral that can move through DeFi rails, support real obligations, and execute by predefined rules. Core V2 is a major step toward turning onchain finance into market infrastructure capable of supporting institutional-scale capital flows through programmable collateral." - Misha Putiatin, co-founder of Symbiotic. Nexus Mutual plans to use Symbiotic for additional DeFi cover capacity, and Cap uses it for credit guarantees. Liquid Lane, announced earlier this month, is one of the first applications built on Core V2: a shared capital layer for instant RWA settlement, where one vault services redemptions across many asset types through a competitive settlement market, while the capital earns between events. Midas has been announced as the first issuer and Fasanara Capital, the $6 billion institutional asset manager, as the first curator. Liquid Lane is also designed to strengthen the markets its capital flows into. Tokenized assets have been difficult to use as collateral because long redemption windows make them slow to liquidate. Through RedStone Settle, Liquid Lane is intended to enable markets such as Aave and Morpho to settle those liquidations on demand, making it easier to support a broader range of tokenized assets as collateral. "Cap brings real, sustainable yield onchain by scaling institutional credit beyond the limits of traditional overcollateralized models. The breakthrough enabling that has been shared collateral: infrastructure combines more efficient access to capital for borrowers with enforceable guarantees for the market. That is what Symbiotic makes possible, and why it has become core to how Cap is building." - Benjamin Sarquis Peillard, Founder and CEO, Cap Core V2 is available today, with audits complete and contracts deployed to mainnet. Builders can integrate collateral-backed applications and access the shared capital base, curators can configure and launch vaults under the updated framework, and capital providers can allocate to a broader set of capital deployment strategies. About Symbiotic Symbiotic powers collateral markets, where capital is committed to financial obligations and enforced by code. It backs products across credit, insurance, and RWA, with Chainlink, Nexus Mutual, ether.fi, and Cap Labs live in production. Symbiotic is backed by Paradigm, Pantera, CyberFund, and Coinbase Ventures. Media gallery